This tool can be a valuable resource for researchers and clinicians as it can assist in the identification of potential disease-causing variants in BRCA1 and BRCA2 genes, which are associated with an increased risk of breast and ovarian cancer [103]. This evidence concerns the gene BRCA1 and ovarian carcinoma.